Les émulsions de type huile-dans-eau jouent un rôle important lors des opérations de ré-injection des eaux de production (PWRI). Ce travail s'intéresse à l'écoulement /rétention de ce type d'émulsions en milieux poreux et à leur impact sur l'injectivité. Deux mécanismes fondamentaux sont distingué selon la valeur du Jamming ratio Jr (taille des restrictions /taille des gouttes): le dépôt dit de surface aux forts Jr et le "straining" (blocage, par le forces capillaires, d'une ou plusieurs gouttes à l'amont d'une restriction) aux faibles Jr.Ce document traite, d'abord, de la physicochimie du dépôt de surface. L'étude en fonction de différents paramètres, tels que la salinité et le débit, permis de décrire la structure et la cinétique du dépôt. Nous avons notamment mis en évidence la formation d'une monocouche compacte é gouttelettes individuelles et montré que la cinétique du dépôt vérifie les lois d'échelle développées pour les colloïdes. L'ensemble de nos résulta conforte la similarité de comportement entre les émulsions stables et diluées et les systèmes colloïdaux.Ensuite, le "straining" est mis en évidence et discuté en fonction des distributions en taille -des restrictions et des gouttes- et des valeurs du nombi capillaire.Enfin, nous avons établi que l'endommagement associé au dépôt de surface peut être très significatif et que les pertes d'injectivité sont prédictibles par une loi de Poiseuille modifiée. Pour le "straining", l'impact est encore plus sévère mais sa vitesse de propagation est plus lente.En conclusion, l'effet de ce type d'émulsion doit être pris en compte pour minimiser les risques et optimiser le schéma de réinjection.

This thesis presents the development and experimental testing of a lower-limb exoskeleton system. The device supplies assistive torque at the knee joint to alleviate the loading at the knee, and thus reduce the muscular effort required to perform activities of daily living. The hypothesis is that the added torque would facilitate the execution of these movements by people who previously had limited mobility. Only four specific movements were studied: level-waking, gradient-walking, sit-to-stand-to-sit and ascending stairs. All three major components of the exoskeleton system, i.e. the exoskeleton actuators and actuator control system, the user intention estimation algorithm, and the mechanical construction of the exoskeleton, were investigated in this work. A leg brace was fabricated in accordance with the biomechanics of the human lower-limb. A single rotational degree of freedom at the knee and ankle joints was placed to ensure that the exoskeleton had a high kinematic compliance with the human leg. The position of the pneumatic actuators and sensors were also determined after significant deliberation. The construction of the device allowed the real-world testing of the actuator control algorithm and the user intention estimation algorithms. Pneumatic artificial muscle actuators, that have high power to weight ratio, were utilized on the exoskeleton. An adaptive fuzzy control algorithm was developed to compensate for the inherent nonlinearities in the pneumatic actuators. Experimental results confirmed the effectiveness of the adaptive controller. The user intention estimation algorithm is responsible for interpreting the user's intended movements by estimating the magnitude of the torque exerted at the knee joint. To accomplish this, the algorithm utilizes biological signals that emanate from the knee extensor and flexor muscles when they are activated. These signals combined with the knee angle data are used as inputs to the estimation algorithm. The output is the magnitude and direction of the estimated torque. This value is then scaled by an assistance ratio, which determines the intensity of the assistive torque provided to the user. The experiments conducted verify the robustness and predictability of the proposed algorithms. Finally, experimental results from the four activities of daily living, affirm that the desired movements could be performed successfully in cooperation with the exoskeleton. Furthermore, muscle activity recorded during the movements show a reduction in effort when assisted by the exoskeleton.

Type 2 diabetes or adult onset diabetes, has been a global epidemic for the past two decades, and the number of new cases accelerates every year. Insulin resistance is one of the major factors behind this, wherein the insulin receptor, which signals to regulate glucose levels, based on the hormone insulin, loses its sensitivity. Obesity is one other major concern which is caused due to the improper balance between the caloric intake and the energy utilized. Gastric bypass surgeries (GBP) are performed to avert obesity. However, a beneficial side-effect is that the state of insulin resistance is reset to near baseline levels within a few days after the procedure. The reason behind this remains unexplained, with possible humoral effects, hypothesized to occur after the bariatric procedure. In this work, high-five insect cell line was utilized to recombinantly produce full length insulin receptors (IR). However commercially sourced IR ectodomains (eIR – soluble version of the full length IR with the completely extracellular α subunits along with extracellular and transmembrane regions of the β subunit), were used to study the interaction. Measuring the kinetics of IR-insulin interactions is critical to improving our understanding of this disease. In this study, a multiplex surface plasmon resonance (SPR) assay was developed for studying the interaction between insulin and the eIR. A scaffold approach was used in which anti-insulin receptor monoclonal antibody 83–7 (Abcam, Cambridge, UK) was first immobilized on the SPR sensorchip by amine coupling, followed by eIR capture. The multiplex SPR system (ProteOn XPR36TM, Bio-Rad Laboratories, Hercules, CA) enabled measurement of replicate interactions with a single, parallel set of analyte injections, whereas repeated regeneration of the scaffold between measurements caused variable loss of antibody activity. The main approach was to replicate the physiological IR-insulin interaction using this assay. It was also observed that insulin at higher concentrations tend to form dimers and hexamers in solution. This was tested using size exclusion chromatography analysis and proved to be true. Therefore an alternative analyte with the similar binding properties and affinity of insulin and at the same time with reduced self- association characteristics was explored. Lispro, the analogue of insulin with reduced self-association properties (generated by swapping of residue 28 and 29 with Lys and Pro respectively) was finally used to study the interaction with eIR. Interactions between recombinant human insulin with eIR-A (A isoform of the insulin receptor ectodomain) followed a two-site binding pattern (consistent with the literature), with a high-affinity site (dissociation constant KD1 = 38.1 ± 0.9 nM) and a low-affinity site (KD2 = 166.3 ± 7.3 nM). The predominantly monomeric insulin analogue Lispro had corresponding dissociation constants KD1 =73.2 ± 1.8 nM and KD2 =148.9 ± 6.1 nM, but the fit to kinetic data was improved when conformational change factor was included in which the high-affinity site was converted to the low-affinity site. Kinetics of interaction of insulin with eIR-A and eIR-B isoforms were then compared. eIR-A bound insulin with apparently higher affinity (with both the binding sites) when compared with eIR-B. This was again consistent with literature that IR-A had two-fold higher affinity for binding insulin than IR-B. The assay was further extended to study the effect of external factors such as glucose, visfatin on this interaction. Glucose (the main biomolecule which is regulated by the IR-insulin interaction) was tested, if it had any direct effect on the interaction. It was observed that glucose did not have any effect on eIR-insulin interactions. Visfatin, an adipocytokine which has been highly debated in literature for its insulin mimetic effects and IR binding properties, was then tested. The standard assay did not provide much insights as the reference channel immobilized with 83-7 monoclonal antibody to the receptor had much affinity for visfatin, leading to non-specific binding and negative responses. Therefore, in an alternative methodology was used - visfatin, Lispro and insulin were immobilized on separate channels along with bovine serum albumin immobilized on reference channel and eIR isoforms used as analyte to study the effect of visfatin on IR. This study showed that visfatin, a higher molecular weight protein compared to insulin, bound both the eIR isoforms. This is consistent with literature that visfatin binds IR at a site distinct from insulin, but the assay described here could not confirm the fact that it mimicked the signalling carried out by IR-insulin binding. Further studies are required to interpret the kinetics of visfatin-eIR interaction. To my knowledge, this is the first SPR assay developed to study eIR-insulin interactions in real-time. This could potentially be extended to study the interaction of insulin with full length insulin receptors and the effect of humoral and other external factors on the interaction, without the need for insulin labelling.

No description available.

No description available.

No description available.

No description available.

No description available.

No description available.

No description available.